Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02300285 · ClinicalTrials.gov registry record · NA
Efficacy of Continuous Glucose Monitoring in Neonates With Hypoglycemia
A NA study, sponsored by Boston Children's Hospital.
- Terminated
- Registry status
- NA
- Development phase
- 6
- Enrollment target
NCT02300285 is a NA study that was terminated before completion, run by Boston Children's Hospital. The registered enrollment target is 6 participants.
The verdict
NCT02300285, a NA study, was terminated before completion, sponsored by Boston Children's Hospital.
- TERMINATED
- Registry status
- NA
- Development phase
- 6 participants
- Enrollment target
Study Summary
Our aim is to determine the feasibility of using continuous glucose monitors (CGMs) in infants with low blood glucose to improve how we care for these infants. To do this we plan on monitoring blood glucose levels with CGMs (instead of only with intermittent bloodsampling) in late-preterm and term infants admitted to the NICU who have had hypoglycemia. To see if using CGMs helps us prevent low blood glucose levels and allows us to find a diagnosis and treat sooner, we will randomize patients into one of two groups: a "CGM group" where the CGM information is made available to the NICU team and a "Standard of Care" group where the CGM information will only be available to the research team. However, if infants in the "Standard of Care" group are noted to have three unrecognized severe low blood glucose levels then the research team will inform the NICU team that this has occurred.
Interventions
- DEVICE Continuous Glucose Monitoring
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2015-02 |
| Est. Completion | 2018-08-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02300285
The ClinicalTrials.gov registry entry for NCT02300285 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston Children's Hospital, which has 462 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Continuous Glucose Monitoring is the first listed.
NCT02300285 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02300285 about?
NCT02300285 is a clinical study titled "Efficacy of Continuous Glucose Monitoring in Neonates With Hypoglycemia". Our aim is to determine the feasibility of using continuous glucose monitors (CGMs) in infants with low blood glucose to improve how we care for these infants. To do this we plan on monitoring blood glucose levels with CGMs (instead of only with intermittent bloodsampling) in late-preterm and term i...
What is the current status of trial NCT02300285?
This trial is currently terminated. It is a NA study. The enrollment target is 6 participants. The study started on 2015-02. Estimated completion is 2018-08-30.
What interventions are being tested in trial NCT02300285?
The interventions under investigation include: Continuous Glucose Monitoring (DEVICE).
Who is sponsoring clinical trial NCT02300285?
This trial is sponsored by Boston Children's Hospital, which has 462 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.